How a New Eczema Treatment Affects Daily Life and Skin Health

This trial is studying how lebrikizumab works for adults with moderate-to-severe eczema in real-world everyday medical practice across Europe. Researchers want to understand whether this medication improves not only your skin symptoms, but also your overall well-being, energy levels, work ability, and quality of life. The study will follow you for about two years to see how the treatment affects you over time.

While this medication has been approved for eczema, doctors want to learn more about how it actually helps patients in daily life — including whether it reduces fatigue, helps people work better, and improves their emotional relationship with their skin. This real-world information will help doctors understand how well the treatment works outside of controlled research settings.